Lung cancer study aims to decode immune secrets
NCT ID NCT07150598
First seen Sep 30, 2025 · Last updated May 22, 2026 · Updated 31 times
Summary
This study will collect and analyze tumor samples from 500 people with advanced non-small cell lung cancer to see how immune markers and gene activity relate to treatment response. Participants give biopsies before and during immunochemotherapy. The goal is to learn, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitätsklinikum Carl Gustav Carus
Dresden, Saxony, 01307, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Köln, Centrum für Integrierte Onkologie (CIO) Köln
Cologne, North Rhine-Westphalia, 50937, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.